CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1699.10-12.25 (-0.72 %)
PREV CLOSE ( ) 1711.35
OPEN PRICE ( ) 1711.00
BID PRICE (QTY) 1697.20 (8)
OFFER PRICE (QTY) 1701.35 (52)
VOLUME 2286
TODAY'S LOW / HIGH ( )1679.00 1741.80
52 WK LOW / HIGH ( )900 1793.5
NSE1696.85-16.4 (-0.96 %)
PREV CLOSE( ) 1713.25
OPEN PRICE ( ) 1738.95
BID PRICE (QTY) 1696.85 (50)
OFFER PRICE (QTY) 1698.30 (13)
VOLUME 41299
TODAY'S LOW / HIGH( ) 1679.00 1738.95
52 WK LOW / HIGH ( )900.05 1799
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.